Miss Out on Nvidia? Two More Innovative AI Chip Stocks Hiding in Plain Sight

AI-driven demand has transformed the semiconductor market: Nvidia’s AI GPUs (e.g., GB200 at up to $70,000; H100 >$20,000 on secondary) have driven operating margins to ~62% and analysts project profits could triple by 2028, supporting lofty justified valuations. The note highlights Broadcom’s 500% post-ChatGPT run (modeled ~52% upside to $506) but favors Marvell (projected 76–100% upside to $147) for its optical chips, custom silicon (Microsoft sources 100% of its optical chips from Marvell), and a planned ~$3.3bn Celestial AI acquisition; Taiwan Semiconductor (TSMC) is framed as a near-monopoly on advanced nodes with raised guidance (mid-20% revenue growth through 2029, AI revenues +50% annually) and modeled ~110% upside to $705.

Analysis

Market structure: AI demand has pushed a winner-take-most dynamic: TSM (node capacity) and NVDA (GPU IP/pricing) capture disproportionate pricing power while networking/optical specialists (MRVL, AVGO) become mandatory complements to hyperscaler stacks. Tens of thousands of dollars per GPU (GB200 $70k, H100 ~$20k) imply gross-margin upside is real and durable over the next 12–36 months as hyperscalers prioritize performance over ASP.

Risk assessment: Key tail risks are geopolitical/export controls (China restrictions), a Taiwan supply shock (natural/disruption), and hyperscaler insourcing of inference chips—each can wipe 20–50% off near-term revenues for exposed vendors. Near-term (days–weeks) volatility will track earnings/order-book updates; medium-term (6–18 months) risk centers on fab lead times and capacity additions; long-term (3–5 years) outcome depends on onshoring subsidies and global fab capex cycles.

Trade implications: Favor durable foundry exposure (TSM) and under-owned optical/custom-silicon plays (MRVL) while using option structures to limit drawdowns in richly priced names (NVDA). Relative-value is attractive: long MRVL vs short AVGO to capture valuation gap; size positions modestly (1–4% each) and use catalysts (TSM guidance, MRVL acquisition close) to scale. Commodities/equipment suppliers (ASML, KLA) are second-order beneficiaries.

Contrarian angles: Consensus overlooks concentration risk—NVDA/TSM coupling (TSM yields/2nm lead) is a single-point-of-failure; supply resilience could be overstated if U.S./EU onshoring accelerates, creating mid-term overcapacity and margin compression. Historical analogs (1999 tech froth) warn that sentiment can outrun fundamentals; prefer asymmetric pays-offs (option spreads, pairs) not outright levered longs.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in TSM (scale into 0.5–1% tranches on 5–10% pullbacks) with a 12–24 month horizon to capture 3–5 year node leadership; trim if revenue guidance falls below mid-20% YoY growth or TSM announces >15% delayed capacity.
• Build a 1.5–2.5% long position in MRVL and simultaneously short 0.75–1.25% AVGO (long MRVL/short AVGO pair) to exploit MRVL’s valuation gap; add on MRVL if it drops >12% or after Celestial AI deal closes; target 6–18 month holding period, take profits if MRVL outperforms AVGO by >25%.
• If bullish on NVDA but risk-averse, buy a 9–12 month 20% OTM call and finance by selling a 3–6 month 40% OTM call (call-debit spread) sized to 0.5–1% portfolio risk to capture continued AI momentum while capping premium spend.
• Allocate 0.5–1% portfolio to geopolitical tail hedges: buy 12–24 month put spreads on TSM or SMH ETFs (e.g., long 25% OTM put, short 40% OTM put) to limit downside from a Taiwan disruption; reduce non-AI legacy semiconductor exposure (e.g., cut INTC allocation by ~50%) and redeploy into foundry/AI-adjacent names.